This Week in HIV Research: Erectile Dysfunction in the Modern Age

This Week in HIV Research: Erectile Dysfunction in the Modern Age

1 of 5
Next >

On the docket this week in the court of newly published HIV research:

  • Is HIV still guilty by association of reducing erectile function among men who have sex with men?
  • Will Australia and San Francisco realistically achieve UNAIDS 90-90-90 "fast track" targets?
  • Can hepatitis C infection act as a proxy for HIV risk among people who inject drugs?
  • Is the live herpes zoster vaccine safe for people living with HIV?

Follow along for a closer look at the verdicts. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: vitanovski for iStock via Thinkstock

On the docket this week in the court of newly published HIV research:

  • Is HIV still guilty by association of reducing erectile function among men who have sex with men?
  • Will Australia and San Francisco realistically achieve UNAIDS 90-90-90 "fast track" targets?
  • Can hepatitis C infection act as a proxy for HIV risk among people who inject drugs?
  • Is the live herpes zoster vaccine safe for people living with HIV?

Follow along for a closer look at the verdicts. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: vitanovski for iStock via Thinkstock